Invention Grant
- Patent Title: Antiviral agents for drug-resistant influenza A
-
Application No.: US16859121Application Date: 2020-04-27
-
Publication No.: US11365174B2Publication Date: 2022-06-21
- Inventor: Nir Ben-Tal , Roger S. Armen , Laurence C. Eisenlohr , Jitendra Belani , Michael Miller , Inbar Fish , Ori Kalid
- Applicant: Thomas Jefferson University , Ramot At Tel-Aviv University LTD.
- Applicant Address: US PA Philadelphia; IL Tel Aviv
- Assignee: Thomas Jefferson University,Ramot At Tel-Aviv University LTD.
- Current Assignee: Thomas Jefferson University,Ramot At Tel-Aviv University LTD.
- Current Assignee Address: US PA Philadelphia; IL Tel Aviv
- Agency: Cozen O'Connor
- Main IPC: C07C311/16
- IPC: C07C311/16 ; C07C311/29 ; A61K31/63 ; A61K31/18 ; A61K31/352 ; A61K31/167 ; A61K31/04 ; A61P31/16
Abstract:
An effective therapeutic agent for the M2 channel comprising sulfonylamide or oxabicyclo structures effective for treating amantadine-resistant influenza A infections, and methods of treating amantadine-resistant influenza A infections through administration of the same.
Information query
